Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK + BLU-U Data for skin cancer treatment
Analyses of long-term data confirm that the continued and clinically meaningful results of ODOMZO (sonidegib) in people with locally advanced basal cell carcinoma (laBCC) are not impacted by concomitant medicines.
Sun Pharmaceutical Industries announced that one of its wholly-owned subsidiaries presented data analyses for two of its speciality medi